News & Updates

Adolescents with tuberculosis (TB), especially those aged >15 years, may develop symptoms and conditions akin to those seen in adults with TB, suggests a study. In addition, there appears to be an increased incidence of severe pulmonary disease leading to pulmonary sequelae.

The University of Hong Kong’s (HKU) hepatitis C virus (HCV) microelimination programme targeting high-risk populations is expanded recently to eligible persons in custody (PICs) following initial success in individuals with history of illicit drug use, needle sharing or imprisonment undergoing rehabilitation in halfway houses or drug rehabilitation centres.

In a meta-analysis of national cohort studies on COVID-19 vaccination across the UK (England, Northern Ireland, Scotland, and Wales), undervaccination was associated with a higher risk of severe COVID-19 outcomes (ie, COVID-19 hospitalization or death) relative to full vaccination.

An analysis of three randomized controlled trials (RCTs) has shown the efficacy and safety of berdazimer gel, a topical, antiviral, nitric oxide-releasing medication, in the treatment of molluscum contagiosum (MC) lesions in patients aged 6 months and older. Application-site pain and erythema are the most common adverse events (AEs) related to treatment.

Patients with liver disease develop antibodies and T-cell responses following three shots of COVID-19 vaccines, while those who have been infected with SARS-CoV-2 develop mild symptoms only, reports a recent study.

Parental smoking, maternal asthma, and frequent lower respiratory tract infections before the age of 7 years are predictive of obstructive sleep apnoea (OSA) development during adulthood, suggests a study.